Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate for PSC with Persistent Cholestasis
NCT04309773Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bezafibrate in Primary Sclerosing Cholangitis (PSC), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
bezafibrate
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT04309773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04309773.